Correction|Volume 16, Issue 22|pp 13693 Correction for: PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
Zhixuan Ren1Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200433, P.R. China, Li Wang2Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, P.R. China, Chaohui Leng3Department of Oncology, Jiujiang University Affiliated Hospital, Jiujiang 332000, P.R. China
- 1Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200433, P.R. China
- 2Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, P.R. China
- 3Department of Oncology, Jiujiang University Affiliated Hospital, Jiujiang 332000, P.R. China
* Equal contribution
Received: November 24, 2024Accepted: December 1, 2024Published: December 31, 2024
Copyright: © 2024 Ren et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors found that name of the last/corresponding author has been mistakenly recorded as Chaohui Leng, and the correct name should be Zhaohui Leng. In addition, the order of the author’s affiliations was also corrected.
The corrected version of the authors list and affiliations are provided below:
Zhixuan Ren1,2,*, Li Wang3,*, Zhaohui Leng1
1Department of Oncology, Jiujiang University Affiliated Hospital, Jiujiang 332000, P.R. China
2Department of Radiation Oncology, Huadong Hospital, Fudan University, Shanghai 200433, P.R. China
3Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, P.R. China
